BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, March 14, 2026
See today's BioWorld MedTech
Home
» Antegenes raises $2.4M in seed round to scale genetic testing for cancer risk in EU
To read the full story,
subscribe
or
sign in
.
Antegenes raises $2.4M in seed round to scale genetic testing for cancer risk in EU
Aug. 19, 2022
By
Bernard Banga
Antegenes OÜ raised $2.4 million in seed funding to deploy its genomic testing for personalized cancer prevention in new markets across Europe.
Financings
Medical technology
Private
Seed
Europe
